These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 36556918)

  • 1. Multiparametric MRI Features of Breast Cancer Molecular Subtypes.
    Szep M; Pintican R; Boca B; Perja A; Duma M; Feier D; Fetica B; Eniu D; Dudea SM; Chiorean A
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.
    Kim JJ; Kim JY; Suh HB; Hwangbo L; Lee NK; Kim S; Lee JW; Choo KS; Nam KJ; Kang T; Park H
    Eur Radiol; 2022 Feb; 32(2):822-833. PubMed ID: 34345946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes.
    Youk JH; Son EJ; Chung J; Kim JA; Kim EK
    Eur Radiol; 2012 Aug; 22(8):1724-34. PubMed ID: 22527371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
    Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
    Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer?
    Montemezzi S; Camera L; Giri MG; Pozzetto A; Caliò A; Meliadò G; Caumo F; Cavedon C
    Eur J Radiol; 2018 Nov; 108():120-127. PubMed ID: 30396643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
    Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
    Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is simultaneous multi-slice readout-segmented echo-planar imaging valuable for predicting molecular subtypes of breast cancer?
    Li X; Zhu H; Sun K; Chai W; Fu C; Yan F
    Eur J Radiol; 2022 May; 150():110232. PubMed ID: 35259708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved discrimination of molecular subtypes in invasive breast cancer: Comparison of multiple quantitative parameters from breast MRI.
    Du S; Gao S; Zhang L; Yang X; Qi X; Li S
    Magn Reson Imaging; 2021 Apr; 77():148-158. PubMed ID: 33309922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in morphological features and minimum apparent diffusion coefficient values among breast cancer subtypes using 3-tesla MRI.
    Kato F; Kudo K; Yamashita H; Wang J; Hosoda M; Hatanaka KC; Mimura R; Oyama-Manabe N; Shirato H
    Eur J Radiol; 2016 Jan; 85(1):96-102. PubMed ID: 26724653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of dynamic contrast-enhanced MRI and diffusion-weighted MR imaging with prognostic factors and subtypes of breast cancers.
    Chen H; Li W; Wan C; Zhang J
    Front Oncol; 2022; 12():942943. PubMed ID: 35992872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Added value of mean and entropy of apparent diffusion coefficient values for evaluating histologic phenotypes of invasive ductal breast cancer with MR imaging.
    Suo S; Zhang D; Cheng F; Cao M; Hua J; Lu J; Xu J
    Eur Radiol; 2019 Mar; 29(3):1425-1434. PubMed ID: 30116958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric MRI model to predict molecular subtypes of breast cancer using Shapley additive explanations interpretability analysis.
    Huang Y; Wang X; Cao Y; Li M; Li L; Chen H; Tang S; Lan X; Jiang F; Zhang J
    Diagn Interv Imaging; 2024 May; 105(5):191-205. PubMed ID: 38272773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of magnetic resonance imaging features with five molecular subtypes of breast cancer.
    Nguyen VT; Duong DH; Nguyen QT; Nguyen DT; Tran TL; Duong TG
    Eur J Radiol Open; 2024 Dec; 13():100585. PubMed ID: 39041054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
    Richard R; Thomassin I; Chapellier M; Scemama A; de Cremoux P; Varna M; Giacchetti S; Espié M; de Kerviler E; de Bazelaire C
    Eur Radiol; 2013 Sep; 23(9):2420-31. PubMed ID: 23652844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multiparametric approach to predict triple-negative breast cancer including parameters derived from ultrafast dynamic contrast-enhanced MRI.
    Ohashi A; Kataoka M; Iima M; Honda M; Ota R; Urushibata Y; Dominik Nickel M; Toi M; Zackrisson S; Nakamoto Y
    Eur Radiol; 2023 Nov; 33(11):8132-8141. PubMed ID: 37286791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between diffusion-weighted imaging and breast cancer biomarkers.
    Martincich L; Deantoni V; Bertotto I; Redana S; Kubatzki F; Sarotto I; Rossi V; Liotti M; Ponzone R; Aglietta M; Regge D; Montemurro F
    Eur Radiol; 2012 Jul; 22(7):1519-28. PubMed ID: 22411304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
    Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
    J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Resonance Imaging Phenotypes of Breast Cancer Molecular Subtypes: A Systematic Review.
    Ab Mumin N; Ramli Hamid MT; Wong JHD; Rahmat K; Ng KH
    Acad Radiol; 2022 Jan; 29 Suppl 1():S89-S106. PubMed ID: 34481705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Axillary Lymph Node Metastasis in Early-stage Triple-Negative Breast Cancer Using Multiparametric and Radiomic Features of Breast MRI.
    Song SE; Woo OH; Cho Y; Cho KR; Park KH; Kim JW
    Acad Radiol; 2023 Sep; 30 Suppl 2():S25-S37. PubMed ID: 37331865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination between HER2-overexpressing, -low-expressing, and -zero-expressing statuses in breast cancer using multiparametric MRI-based radiomics.
    Zheng S; Yang Z; Du G; Zhang Y; Jiang C; Xu T; Li B; Wang D; Qiu Y; Lin D; Zhang X; Shen J
    Eur Radiol; 2024 Sep; 34(9):6132-6144. PubMed ID: 38363315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.